Company page
Immatics N.v.
Immatics N.V. is a public company traded under the ticker IMTX in the American market. The company has a market capitalization of approximately $1.22 billion. Immatics focuses on developing innovative cancer immunotherapies.
- Ticker
- IMTX:NASDAQ
- Asset type
- Stock
- Market cap
- $1.22B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD